- Jazz Pharmaceuticals (NASDAQ:JAZZ) on Thursday appointed Renee Gala, Jazz's President and Chief Operating Officer, as the President and Chief Executive Officer, effective August 11, 2025, when she will also join the Board.
- She will succeed co-founder, Chairperson and CEO Bruce Cozadd, who informed